Literature DB >> 8054814

The effect of donor-specific transfusion and cyclosporin A on small bowel transplantation in the rat.

S F Santiago1, M Fukuzawa, T Azuma, R Nezu, K Imura, Y Takagi, A Okada.   

Abstract

Pre-transplant blood transfusions are given as a means of desensitization to reduce the required dose of cyclosporin A (CsA). In this study, the effect of pretransplant blood transfusion on host survival and T-cell function against alloantigen were investigated. Male Lewis rats (RT1(1)) were used as the recipients in all experiments, and male DA rats (RT1a) were used as the blood and small bowel donors, and as a source of allogeneic stimulator cells. Male BUF rats (RT1b) were used as donors of third party blood, and of allo-stimulator cells in a delayed-type hypersensitivity (DTH) response. In our experimental design, Lewis rats were divided into the following groups according to the type of administration: (1) a donor-specific blood transfusion (DST) 8 days preoperatively and a concurrent 5-day course of CsA at 10 mg/kg per day; (2) a nonspecific third party blood transfusion (NST) and CsA at 10 mg/kg per day from day 8 to day 4 preoperatively; (3) CsA alone from day 8 to day 4 preoperatively; (4) DST alone 8 days preoperatively; or (5) no treatment, being the control group. Postoperative treatment consisted of CsA at 2.5 mg/kg per day for 30 days. Rats conditioned with NST plus CsA, CsA alone, DST alone, and the untreated control rats survived for 7.2 +/- 1.2, 9.0 +/- 2.2, 6.8 +/- 0.4, and 7.4 +/- 1.6 days, respectively. In contrast, the five rats conditioned with DST plus CsA survived for 100 days or more.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054814     DOI: 10.1007/bf01427036

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  30 in total

1.  Transfusion-induced skin allograft enhancement across an H-2 class-I mismatch is caused by a clonal deletion of donor-specific cytotoxic T-lymphocyte precursors within the allograft.

Authors:  E van Twuyver; W M Kast; R J Mooijaart; C J Melief; L P de Waal
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

2.  Small intestinal transplantation in a child using cyclosporine.

Authors:  O J Goulet; Y Révillon; N Cerf-Bensussan; C Nezelof; A Fischer; C Buisson; P Hubert; F Lokiec; H Martelli; P Niaudet
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

3.  Effect of blood transfusions on subsequent kidney transplants.

Authors:  G Opelz; D P Sengar; M R Mickey; P I Terasaki
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

4.  Pretransplant transfusion and cyclosporine-induced enhancement of rabbit skin allografts. Donor-specific versus third-party blood.

Authors:  H P King; G J Clunie; L J Dumble
Journal:  Transplantation       Date:  1984-04       Impact factor: 4.939

5.  Prolongation of rat cardiac allografts by pretransplant administration of blood transfusions and cyclosporin A.

Authors:  C M Miller; G P Martinelli; D Racelis; H Schanzer
Journal:  Transplantation       Date:  1982-03       Impact factor: 4.939

6.  The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions.

Authors:  D L Phelan; G E Rodey; C B Anderson
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

7.  Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.

Authors:  P Ruiz; T M Coffman; D N Howell; J Straznickas; M W Scroggs; W M Baldwin; P E Klotman; F Sanfilippo
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

8.  Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.

Authors:  J M Cecka; J Cicciarelli; M R Mickey; P I Terasaki
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

9.  Structure and function of orthotopic small bowel allografts in rats treated with cyclosporine.

Authors:  K K Lee; W H Schraut
Journal:  Am J Surg       Date:  1986-01       Impact factor: 2.565

10.  Improved survival after allogeneic small intestinal transplantation in the rat using cyclosporine immunosuppression.

Authors:  R P Harmel; M Stanley
Journal:  J Pediatr Surg       Date:  1986-03       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.